IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Clinical Neuropharmacology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.96

h-Index

2022-2023

 83

Rank

2022-2023

 15342

SJR

2022-2023

 0.293

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Clinical Neuropharmacology
Abbreviation Clin. Neuropharmacol.
Publication Type Journal
Subject Area, Categories, Scope Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)
h-index 83
Overall Rank/Ranking 15342
SCImago Journal Rank (SJR) 0.293
Impact Score 0.96
Publisher Lippincott Williams and Wilkins Ltd.
Country United States
ISSN 1537162X, 03625664
Best Quartile Q3
Coverage History 1982-2022




Aim and Scope


Clinical Neuropharmacology is a peer-reviewed journal devoted to the pharmacology of the nervous system in its broadest sense. Coverage ranges from such basic aspects as mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptoms. The journal publishes original articles and brief reports, invited and submitted reviews, and letters to the editor. A regular feature is the Patient Management Series: in-depth case presentations with clinical questions and answers.


About Clinical Neuropharmacology


Clinical Neuropharmacology is a journal covering the technologies/fields/categories related to Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of Clinical Neuropharmacology is 15342. According to SCImago Journal Rank (SJR), this journal is ranked 0.293. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 83. The best quartile for this journal is Q3.

The ISSN of Clinical Neuropharmacology journal is 1537162X, 03625664. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Neuropharmacology is cited by a total of 195 articles during the last 3 years (Preceding 2022).


Clinical Neuropharmacology Impact IF 2022-2023


The Impact IF 2022 of Clinical Neuropharmacology is 0.96, which is computed in 2023 as per its definition. Clinical Neuropharmacology IF is decreased by a factor of 0.39 and approximate percentage change is -28.89% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Clinical Neuropharmacology Impact IF 2023 Prediction


Impact IF 2022 of Clinical Neuropharmacology is 0.96. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Clinical Neuropharmacology. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.96
2021 1.35
2020 1.30
2019 1.43
2018 1.31
2017 1.34
2016 1.69
2015 2.23
2014 2.48

Clinical Neuropharmacology h-index


  Table Setting

Clinical Neuropharmacology has an h-index of 83. It means 83 articles of this journal have more than 83 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Clinical Neuropharmacology ISSN


The ISSN of Clinical Neuropharmacology is 1537162X, 03625664. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Clinical Neuropharmacology Rank and SCImago Journal Rank (SJR)


The overall rank of Clinical Neuropharmacology is 15342. According to SCImago Journal Rank (SJR), this journal is ranked 0.293. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Clinical Neuropharmacology by Year


Year SJR
2023/2024 Coming Soon
2022 0.293
2021 0.334
2020 0.486
2019 0.440
2018 0.509
2017 0.506
2016 0.637
2015 0.788
2014 0.666

Ranking of Clinical Neuropharmacology by Year


Year Ranking
2023/2024 Coming Soon
2022 15342
2021 13751
2020 10317
2019 10948
2018 9376
2017 9118
2016 7425
2015 6021
2014 7001

Clinical Neuropharmacology Publisher


Table Setting

Clinical Neuropharmacology is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 1982-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Clinical Neuropharmacology is Clin. Neuropharmacol.. This abbreviation ('Clin. Neuropharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Clinical Neuropharmacology


If your research field is/are related to Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Clinical Neuropharmacology?

Clinical Neuropharmacology latest impact IF is 0.96. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.48 (2014) and 0.96 (2022), respectively, in the last 9 years. Moreover, its average IS is 1.57 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Clinical Neuropharmacology?

The Clinical Neuropharmacology has an SJR (SCImago Journal Rank) of 0.293, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.788 in 2015 and the lowest being 0.293 in 2022. Furthermore, the average SJR of the Clinical Neuropharmacology over the previous 9-year period stands at 1.57.


What's the latest h-index of the Clinical Neuropharmacology?

The latest h-index of the Clinical Neuropharmacology is 83.


Who's the publisher of the Clinical Neuropharmacology?

The Clinical Neuropharmacology is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.


What's the current ranking of the Clinical Neuropharmacology?

The Clinical Neuropharmacology is currently ranked 15342 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 6021 in 2015 and its lowest position of 15342 in 2022.


What's the abbreviation or short name for the Clinical Neuropharmacology?

The standard ISO4 abbreviation for the Clinical Neuropharmacology is Clin. Neuropharmacol..


Is the "Clinical Neuropharmacology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Clinical Neuropharmacology is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.


What's the scope or major areas of the Clinical Neuropharmacology?

The Clinical Neuropharmacology encompasses the following areas:

  • Neurology (clinical)
  • Pharmacology
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Clinical Neuropharmacology?

The Clinical Neuropharmacology is assigned the following International Standard Serial Numbers (ISSN): 1537162X, 03625664.


What's the best quartile of the Clinical Neuropharmacology?

The best quartile for the Clinical Neuropharmacology is Q3 (2022).


What's the coverage history of the Clinical Neuropharmacology?

The Clinical Neuropharmacology coverage history can be summarized as follows: 1982-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 5639 Maney Publishing 43 2.38
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Journal of Business Finance and Accounting journal 3221 Wiley-Blackwell Publishing Ltd 84 3.68
Journal of Supply Chain Management journal 378 Wiley-Blackwell 104 12.58
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
World Englishes journal 4960 Wiley-Blackwell 60 1.97
Canadian Journal of Education journal 17961 Canadian Society for the Study of Education (CSSE) 41 0.39
Archiv fur Geflugelkunde journal 28770 Verlag Eugen Ulmer 30 0.00
Expert Review of Clinical Pharmacology journal 5241 Taylor and Francis Ltd. 53 4.10
Poljoprivreda journal 20724 Faculty of Agriculture in Osijek 14 0.67

Check complete list




Year wise Impact Score (IS) of Clinical Neuropharmacology

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.96
2021 1.35
2020 1.30
2019 1.43
2018 1.31
2017 1.34
2016 1.69
2015 2.23
2014 2.48



Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All